According to the internal infection control protocols, all patients were scheduled to undergo routine serological test for viral hepatitis (i.e.: anti-HCV, anti-HBs, anti-HBc and HBsAg) and transaminases, at the time of first HD and then every 3 months. Here, KRT88P is linked to infection.